DAFTAR PUSTAKA
1. WHO. Deaths from Coronary Heart Disease [Online Journal] 2013 [diunduh 25 September 2013]. Tersedia dari: http://www.who.int.
2. Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan RI. Riset Kesehatan Dasar, 2007.
3. Gibbons J, Chatterjee K, Daley J, Deedwania P, Douglas J, Ferguson T, dkk. ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina. ACC/AHA Practice Guidelines, 2002.
4. Fuster V, Alexander RW, O'Rourke RA. Cardiac Catheterization, Cardiac Angiography and Coronary Blood Flow and Pressure Measurements. Dalam: Hurst's The Heart. Edisi ke-11.McGraw Hill, 2004, hal: 483-537
5. McCaig LF, Burt CW. National Hospital Ambulatory Medical Care Survey: 1999 emergency department summary. Adv. Data. 2001;320:1–34.
6. Hansson GK. Inflammation, Atherosclerosis, and Coronary Artery Disease. N Engl J Med. 2005;352(16):1685-95.
7. Qiao JH, Fishbein MC. The severity of coronary atherosclerosis at sites of plaque rupture with occlusive thrombosis. J Am Coll Cardiol. 1991;17(5):1138-42.
8. Hatmi ZN, Saeid AK, Broumand MA, Khoshkar SN, Danesh ZF. Multiple inflammatory prognostic factors in acute coronary syndromes: a prospective inception cohort study. Acta Med Iran. 2010;48(1):51-7.
9. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann. Intern. Med.2009;151(7):483–495.
11. Olivares R, Ducimetière P, Claude JR. Monocyte count: a risk factor for coronary heart disease. Am. J. Epidemiol.1993;137(1):49–53.
12. Guasti L, Dentali F, Castiglioni L, Maroni L, Marino F, Squizzato A, dkk. Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. A systematic review on more than 34,000 subjects. Thromb. Haemost. 201;106(4):591–599.
13. Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F. Predictive value of elevated neutrophil–lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin. Chim. Acta. 2008;395(1–2):27–31. 14. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, dkk.
Which white blood cell subtypes predict increased cardiovascular risk. J Am Coll. Cardiol.2005;45(10):1638–1643.
15. Zazula AD, Précoma-Neto D, Gomes AM, Kruklis H, Franco GB, Yared R, dkk. An assessment of neutrophils/ lymphocytes ratio in patients suspected of acute coronary syndrome. Arq. Bras. Cardiol.200;90(1):31–36.
16. Suliman M, Juma B, Almadhani A, Pathare AV, Alkindi SS, Werner UF. Predictive value of neutrophil to lymphocyte ratio in outcomes of patients with acute coronary syndrome. Arch. Med. Res.2010; 41(8):618–622.
17. Tamhane U, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am. J. Cardiol2008;102(6):653– 657.
18. Kaya H, Ertas F, Islamoglu Y, Kaya Z, Atilgan ZA, Çil H, dkk. Association Between Neutrophil to Lymphocyte Ratio and Severity of Coronary Artery Disease.Clin Appl Thromb Hemost.2013;00(0):1-5
19. Achar S, Kundu S, Norcross W. Diagnosis of acute coronary syndrome. Am Fam Physician.2005;72:119-26.
20. Perhimpunan Dokter Spesialis Kardiovaskuler Indonesia. Pedoman Tatalaksana Penyakit Kardiovaskuler di Indonesia. Edisi ke-3;2012:3-54. 21. Hamm CW, Heeschen C, Falk E, Fox KA. Acute coronary syndromes:
Lüscher, P.W. Serruys, penyunting. The ESC Textbook of Cardiovascular Medicine. Edisi ke-2. Oxford University Press, Oxford; 2009.hlm:333–366. 22. Wright RS, Cynthia DA, Jeffrey L, Bridges CR, Casey DE, Ettinger SM, dkk.
ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non_ST-Elevation Myocardial Infarction (Updating the 2007 Guideline). J. Am. Coll. Cardiol.2011;57:1920-1959. 23. Levine G, Eric R, James C, Bailey S, Bittl JA, Cercek B, dkk.
ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation.2011;124:1-82. 24. Budaj A, David B, Gabriel S, Goodman SG, Dabbous OH, Fox KA, dkk.
Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: Insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J.2003;146 :999-1006.
25. Bender J, Russel K, Rosenfeld E, Chaundry S, Oxford American Handbook of Cardiology. New York : Oxford. 2011.hlm.256-260.
26. Packard RRS, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clinical Chemistry,2008;54:24-38.
27. Ismail D. Patofisiologi Sindroma Koroner Akut. Dalam : Bawazier LA, Alwi I, Syam AF dkk. penyunting. Prosiding Simposium Pendekatan Holistik Penyakit Kardiovaskuler. Jakarta : Pusat Informasi dan Penerbitan Bagian Ilmu Penyakit Dalam FK UI;2001.hlm.22-31.
28. Therax P, Foster V. Acute Coronary Syndrome: Unstable Angina and non Q Wave Myocard Infarction. Circulation,1998;97:1195-1206.
30. Rauch U, Osende JI, Fuster V, Badimon J, Fayad Z, Chesebro J. Thrombus Formation on Atherosclerotic Plaques : Pathogenesis and Clinical Consequences. Ann Intern Med.2001;134:224-38.
31. Kumar A, Cannon P. Acute Coronary Syndromes: Diagnosis and Management, Part I Mayo Clin Proc.2009;84(10):917-93.
32. Thygesen K. Alpert JS. Jaffe A. Simoons M, Chaitman B, White H. Third Universal Definition of Myocardial Infarction. J Am Coll Cardiol. 2012;60(16):1581-1598.
33. Effendi Z, Peranan Leukosit Sebagai Anti Inflamasi Alergik Dalam Tubuh [Online Journal] 2003 [diunduh 25 September 2013]. Tersedia dari: http://library.usu.ac.id
34. Sherwood L. Darah. Dalam: Fisiologi Manusia: Dari sel ke sel. Edisi ke-6. Jakarta. EGC. 2011,hlm 428-431
35. Madjid M, Awan I, Willerson J, Casscells S. Leukocyte Count and Coronary Heart Disease, Implications for Risk Assessment. JACC.2004;44 (10):1945– 56.
36. Ates AH, Canpolat U, Yorgun H, Baris E¸ Kaya, Sunman H, dkk.. Total white blood cell count is associated with the presence, severity and extent of coronary atherosclerosis detected by dual-source multislice computed tomographic coronary angiography. Cardiol. J.2011;18(4):371–377.
37. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA,1998;279 (18):1477–1482.
38. Munir TA, Afzal MN, Habib-ur-Rehman. Baseline leukocyte count and acute coronary syndrome: predictor of adverse cardiac events, long and short-term mortality and association with traditional risk factors, cardiac biomarkers and C-reactive protein. J Ayub Med Coll Abbottabad. 2009;21(3):46-50.
39. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med,1999;340:115–26.
40. Takahashi K, Takeya M, Sakashita N. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and
41. Naruko T, Ueda M, Haze K, Van der Wal AC, Van der Loos, Chris M, dkk. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation.2002;106:2894–900.
42. Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol.2003;41:S15–22.
43. Hoffbrand AV, Pettit JE. Kapita Selekta: Hematologi (Essential Haematologi) Edisi Ke-2.hlm.102-105
44. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: Molecules, Function and Pathophysiological Aspects. Laboratory Investigation. 2000;80:617-646.
45. Cascao R, Rosario H, Fonseca J. Neutrophils: warriors and commanders in immune mediated inflammatory disease. Acta Reumatol Port,2009;34:313-326.
46. Carbone F, Nencioni A, Mach F, Vuilleumier N, Montecucco F. Pathophysiological role of neutrophils in acute myocardial infarction. Thrombosis and Haemostasis. 2013; 110(2):1-14.
47. Ducloux D, Challier B, Saas P, Tiberghien P, Chalopin JM. CD4 cell lymphopenia and atherosclerosis in renal transplant recipients. J Am Soc Nephrol. 2003 Mar;14(3):767-72.
48. Ommen SR, Gibbons RJ, Hodge DO, Thomson SP. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol. 1997;79:812– 814.
49. Blum A, Sclarovsky S, Rehavia E, Shohat B. Levels of T-lymphocyte subpopulations, interleukin-1, and soluble interleukin-2 receptor in acute myocardial infarction. Am Heart J.1994; 127:1226 –1230.
50. Mor A, Luboshits G, Planer D, Keren G, George J. Altered status of CD4 and CD25 and regulatory T cells in patients with acute coronary syndromes. Eur Heart J.2006;27:2530 –2537.
52. Gupta S, Agrawal A, Agrawal S, Su H, Gollapudi S. A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis. Immun Ageing.2006;3:5.
53. Azab B, Zaher M, Weiserbs K, Torbey E, Lacossiere K, Gaddam S, dkk. Usefulness of neutrophil to lymphocyte ratio in predicting short and long term mortality after non-ST-elevation myocardial infarction. Am. J. Cardiol.2010;106(4):470–476.
54. Dong-bao LI, Qi H, Zhi L, Jing LI, Li-qing XU, Shan W, dkk. Association between inflammatory mediators and angiographic morphologic features indicating thrombus formation in patients with acute myocardial infarction. Chin. Med. J. 2009;122(15), 1738–1742.
55. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt D. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am. J. Cardiol.2006;97(7): 993– 996.
56. Poludasu S, Cavusoglu E, Khan W, Marmur JD. Neutrophil to lymphocyte ratio as a predictor of long-term mortality in African Americans undergoing percutaneous coronary intervention. Clin. Cardiol.2009;32(12):E6–E10. 57. Núñez J, Núñez E, Bodí V, Sanchis J, Miñana G, Mainar L,dkk. Usefulness
of the neutrophil to lymphocyte ratio in predicting long-term mortality in STsegment elevation myocardial infarction. Am. J. Cardiol.2008;101(6):747– 752.
58. Cho KH, Jeong MH, Ahmed K, Hachinohe D, Choi HS, Chang SY, dkk. Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio inpatients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am. J. Cardiol.2011;107(6): 849–856.
59. Neeland IJ, Patel RS, Eshtehardi P, Dhawan S, McDaniel MC, Rab ST, dkk. Coronary Angiographic Scoring Systems An Evaluation of Their Equivalence and Validity. Am Heart J. 2012;164(4):547-552.e1
61. Korn H, Graefe V, Ohlow M, Yu J, Huegl B, Wagner A. Acute Coronary Syndrome without Significant Stenosis on Angiography: Characteristics and Prognosis. Tex Heart Inst J 2008;35(4):406-12
62. Harris P, Behar V, Conley M, Harrell F, Lee K, Peter R. The Prognostic Significance of 50% Coronary Stenosis in Medically Treated Patients with Coronary Artery Disease. Circulation, 1980;62(2):1-10
63. Zencirci AE, Zencirci EG, Degirmencioglu Aleks, Karakus G¸ Ekmekçi A, Ozden Kıvılcım, dkk. The Predictive Value of Gensini Score in the Clinical Outcomes in Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. JACC. 2013; 62(18):C205
64. Kokubu N, Hase M, Nishida J, Funayama N, Mochizuki A, Muranaka A, dkk. Impacts of Gensini Score for Coronary Angiographic Severity on Outcomes of Out-of-Hospital Cardiac Arrest due to Acute Myocardial Infarction Patients. The American Journal of Cardiology, 2011;107(8):5A
65. Sinning C, Lillpopp L, Appelbaum S, Ojeda F, Zeller T, Schnabel R. Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application. Clinical Research in Cardiology, 2013;102(7):495-503
